| Literature DB >> 9053547 |
Abstract
Peroxisomal beta-oxidation is involved in the degradation of different fatty acids or fatty acid derivatives including eicosanoids (prostaglandins, leukotrienes, thromboxanes), dicarboxylic fatty acids, very long-chain fatty acids, pristanic acid, bile acid intermediates (di- and trihydroxycoprostanoic acids), and xenobiotics. Separate beta-oxidation systems are probably active inside peroxisomes, each acting on a distinct set of substrates, as suggested by the discovery of multiple acyl-CoA oxidases. Using specific substrates or selective conditions, we can distinguish in rat liver the action of acyl-CoA oxidases (type I and II), a pristanoyl-CoA oxidase and a trihydroxycoprostanoyl-CoA oxidase, and, in in human liver, of acyl-CoA oxidase (type I and II) and a branched-chain acyl-CoA oxidase. When incubated with suitable CoA-esters, these different oxidases can be measured in a similar fashion by following fluorimetrically the dimerization of homovanillic acid, catalysed by peroxidase in the presence of hydrogen peroxide. The optimal assay conditions and possible pitfalls in this type of coupled assay are discussed. This knowledge can be used to reveal the existence of peroxisomal disorders in which only one acyl-CoA oxidase is deficient.Entities:
Mesh:
Substances:
Year: 1995 PMID: 9053547 DOI: 10.1007/bf00711435
Source DB: PubMed Journal: J Inherit Metab Dis ISSN: 0141-8955 Impact factor: 4.982